J Pedersen-Bjergaard

8.7k citations

104 papers · 6.2k indexed · h-index 42

Hematology top 0.1%
Molecular Biology top 2%
Public Health, Environmental and Occupational Health top 0.5%
Genetics top 0.5%
Oncology top 2%

Co-authors: Preben Philip Mette Klarskov Andersen Debes Hammershaimb Christiansen Severin Olesen Larsen JD Rowley Diane Roulston Michael Pedersen G Jensen
Topics: Acute Myeloid Leukemia Research (66 papers)Acute Lymphoblastic Leukemia research (29 papers)Chronic Lymphocytic Leukemia Research (26 papers)
Cited by: Hematology Genetics Public Health, Environmental and Occupational Health
Journals: New England Journal of Medicine Proceedings of the National Academy of Sciences The Lancet
Partner nations: Denmark United States Sweden

In The Last Decade

J Pedersen-Bjergaard

103 papers receiving 5.9k citations

Peers

Countries citing papers authored by J Pedersen-Bjergaard

Since Specialization

Citations

This map shows the geographic impact of J Pedersen-Bjergaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Pedersen-Bjergaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Pedersen-Bjergaard more than expected).

Fields of papers citing papers by J Pedersen-Bjergaard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Pedersen-Bjergaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Pedersen-Bjergaard. The network helps show where J Pedersen-Bjergaard may publish in the future.

Co-authorship network of co-authors of J Pedersen-Bjergaard

This figure shows the co-authorship network connecting the top 25 collaborators of J Pedersen-Bjergaard. A scholar is included among the top collaborators of J Pedersen-Bjergaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Pedersen-Bjergaard. J Pedersen-Bjergaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	NPM1 mutations in therapy-related acute myeloid leukemia with uncharacteristic features 2008 ·Leukemia ·Morten Andersen,Mie Andersen,Debes Hammershaimb Christiansen,J Pedersen-Bjergaard	40
2	Mutations of the PTPN11 gene in therapy‐related MDS and AML with rare balanced chromosome translocations 2007 ·Genes Chromosomes and Cancer ·Debes Hammershaimb Christiansen,(unknown),Mette K. Andersen,J Pedersen-Bjergaard	21
3	Genetic Pathways in the Pathogenesis of Therapy-Related Myelodysplasia and Acute Myeloid Leukemia 2007 ·Hematology ·J Pedersen-Bjergaard,Morten Andersen,Mette Klarskov Andersen	47
4	Alternative genetic pathways and cooperating genetic abnormalities in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemia 2006 ·Leukemia ·J Pedersen-Bjergaard,Debes Hammershaimb Christiansen,(unknown),(unknown)	98
5	Methylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemia 2003 ·Leukemia ·Debes Hammershaimb Christiansen,Mette Klarskov Andersen,J Pedersen-Bjergaard	130
6	Causality of myelodysplasia and acute myeloid leukemia and their genetic abnormalities 2002 ·Leukemia ·J Pedersen-Bjergaard,(unknown),(unknown),Flemming Skovby	41
7	Balanced chromosome abnormalities inv(16) and t(15;17) in therapy‐related myelodysplastic syndromes and acute leukemia: Report from an International Workshop† 2002 ·Genes Chromosomes and Cancer ·Mette Klarskov Andersen,Richard A. Larson,Nils Mauritzson,Susanne Schnittger,Suresh C. Jhanwar,J Pedersen-Bjergaard	99
8	Duplication or amplification of chromosome band 11q23, including the unrearranged MLL gene, is a recurrent abnormality in therapy‐related MDS and AML, and is closely related to mutation of the TP53 gene and to previous therapy with alkylating agents 2001 ·Genes Chromosomes and Cancer ·Mette Klarskov Andersen,Debes Hammershaimb Christiansen,Maria Kirchhoff,J Pedersen-Bjergaard	79
9	Increased frequency of dicentric chromosomes in therapy-related MDS and AML compared to de novo disease is significantly related to previous treatment with alkylating agents and suggests a specific susceptibility to chromosome breakage at the centromere 2000 ·Leukemia ·(unknown),J Pedersen-Bjergaard	52
10	Inversion of chromosome 16 and uncommon rearrangements of the CBFB and MYH11 genes in therapy-related acute myeloid leukemia: rare events related to DNA-topoisomerase II inhibitors? 1998 ·Journal of Clinical Oncology ·(unknown),Michelle M. Le Beau,J Pedersen-Bjergaard	69
11	Balanced chromosome aberrations in leukemias following chemotherapy with DNA-topoisomerase II inhibitors. 1998 ·Journal of Clinical Oncology ·J Pedersen-Bjergaard,Mie Andersen,B Johansson	65
12	BEAM+autologous stem cell transplantation in malignant lymphoma: 100 consecutive transplants in a single centre. Efficacy, toxicity and engraftment in relation to stem‐cell source and previous treatment 1998 ·European Journal Of Haematology ·Christian H. Geisler,Mads Hansen,Niels Smedegaard Andersen,Peter de Nully Brown,Lise Christensen,Ebbe Dickmeiss,Jens Ersbøll,(unknown),Morten Bagge Hansen,Birgitte Ravn Juhl,(unknown),J Pedersen-Bjergaard	6
13	Long-term survival and development of secondary malignancies in patients with acute myeloid leukemia treated with aclarubicin or daunorubicin plus cytosine arabinoside followed by intensive consolidation chemotherapy in a Danish national phase III trial 1997 ·Leukemia ·Peter de Nully Brown,(unknown),(unknown),(unknown),Kirsten Grønbæk,Erik Hippe,(unknown),K Thorling,Hans H. Storm,J Pedersen-Bjergaard,(unknown)	11
14	High risk of therapy-related leukemia after BEAM chemotherapy and autologous stem cell transplantation for previously treated lymphomas is mainly related to primary chemotherapy and not to the BEAM–transplantation procedure 1997 ·Leukemia ·J Pedersen-Bjergaard,Michael Pedersen,(unknown),Carsten Geisler	61
15	The prognostic significance of chromosomal analysis and immunophenotyping in 117 patients with de novo acute myeloid leukemia 1997 ·Leukemia Research ·Peter de Nully Brown,Jesper Jurlander,J Pedersen-Bjergaard,(unknown),Christian H. Geisler	26
16	Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancer. 1992 ·Journal of Clinical Oncology ·J Pedersen-Bjergaard,Torben Sigsgaard,Dorte Nielsen,Susanne B. Gjedde,Preben Philip,M Hansen,Severin Olesen Larsen,Mikael Rørth,Henning T. Mouridsen,P Dombernowsky	99
17	Two different classes of therapy-related and de-novo acute myeloid leukemia? 1991 ·Cancer Genetics and Cytogenetics ·J Pedersen-Bjergaard,Preben Philip	86
18	High risk of therapy-related leukemia and preleukemia after therapy with prednimustine, methotrexate, 5-fluorouracil, mitoxantrone, and tamoxifen for advanced breast cancer 1990 ·Cancer ·Michael Andersson,Preben Philip,J Pedersen-Bjergaard	28
19	Follicular low‐grade non‐Hodgkin's lymphoma: Long‐term outcome with or without tumor progression 1989 ·European Journal Of Haematology ·Jens Ersbøll,Henrik B. Schultz,J Pedersen-Bjergaard,Nis I. Nissen	75
20	Cytogenetic, clinical, and cytologic characteristics of radiotherapy-related leukemias 1988 ·Cancer Genetics and Cytogenetics ·Preben Philip,J Pedersen-Bjergaard	29

About J Pedersen-Bjergaard

J Pedersen-Bjergaard is a scholar working on Hematology, Genetics and Immunology and Allergy, having authored 104 papers that have together received 6.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (66 papers), Acute Lymphoblastic Leukemia research (29 papers) and Chronic Lymphocytic Leukemia Research (26 papers). The work is most often cited by research in Hematology (4.2k citations), Genetics (1.2k citations) and Public Health, Environmental and Occupational Health (1.8k citations). J Pedersen-Bjergaard has collaborated with scholars based in Denmark, United States and Sweden. Frequent co-authors include Preben Philip, Mette Klarskov Andersen, Debes Hammershaimb Christiansen, Severin Olesen Larsen, JD Rowley, Diane Roulston, Michael Pedersen, G Jensen, Morten Andersen and Jens Ersbøll. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact